These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 34672802)
1. Response to Mishra Krsak M; Harry BL; Palmer BE; Franco-Paredes C Viral Immunol; 2021 Nov; 34(9):659-660. PubMed ID: 34672802 [No Abstract] [Full Text] [Related]
2. Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone. Larkin H JAMA; 2023 Feb; 329(7):531. PubMed ID: 36723971 [No Abstract] [Full Text] [Related]
3. Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations. Efrati S; Catalogna M; Abu Hamad R; Hadanny A; Bar-Chaim A; Benveniste-Levkovitz P; Levtzion-Korach O Sci Rep; 2021 Aug; 11(1):16543. PubMed ID: 34400714 [TBL] [Abstract][Full Text] [Related]
4. Re: "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2" by Krsak Mishra BK; Bhattacharya D; Kshatri JS; Pati S Viral Immunol; 2021 Nov; 34(9):658. PubMed ID: 34672807 [No Abstract] [Full Text] [Related]
5. Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination. Lippi G; Sciacovelli L; Trenti T; Plebani M; Clin Chem Lab Med; 2021 Jul; 59(8):1333-1335. PubMed ID: 33578505 [No Abstract] [Full Text] [Related]
6. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection. Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374 [TBL] [Abstract][Full Text] [Related]
7. Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide? Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2021 Dec; 385(25):e100. PubMed ID: 34910868 [No Abstract] [Full Text] [Related]
8. Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign. Ferrari D; Mangia A; Spanò MS; Zaffarano L; Viganò M; Di Resta C; Locatelli M; Ciceri F; De Vecchi E Clin Chem Lab Med; 2021 Nov; 59(12):2019-2026. PubMed ID: 34614550 [TBL] [Abstract][Full Text] [Related]
10. Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components. Priyanka ; Choudhary OP; Singh I Travel Med Infect Dis; 2021; 39():101911. PubMed ID: 33186686 [No Abstract] [Full Text] [Related]
11. The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity. Abbasi J JAMA; 2021 Nov; 326(18):1781-1782. PubMed ID: 34673883 [No Abstract] [Full Text] [Related]
12. Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'. Westhoff TH; Seibert FS; Anft M; Blazquez-Navarro A; Skrzypczyk S; Doevelaar A; Hölzer B; Paniskaki K; Dolff S; Wilde B; Witzke O; Braun J; Stervbo U; Babel N Ann Rheum Dis; 2021 Oct; 80(10):e162. PubMed ID: 34272253 [No Abstract] [Full Text] [Related]
13. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer. Ehmsen S; Asmussen A; Jeppesen SS; Nilsson AC; Østerlev S; Vestergaard H; Justesen US; Johansen IS; Frederiksen H; Ditzel HJ Cancer Cell; 2021 Aug; 39(8):1034-1036. PubMed ID: 34348121 [No Abstract] [Full Text] [Related]
14. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days. Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R Front Immunol; 2021; 12():726960. PubMed ID: 34671348 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response. Borgogna C; De Andrea M; Griffante G; Lai A; Bergna A; Galli M; Zehender G; Castello L; Ravanini P; Cattrini C; Mennitto A; Gennari A; Gariglio M J Med Virol; 2021 Dec; 93(12):6444-6446. PubMed ID: 34260066 [No Abstract] [Full Text] [Related]
16. Effects of Vaccination and Previous Infection on Omicron Infections in Children. Lin DY; Gu Y; Xu Y; Zeng D; Wheeler B; Young H; Sunny SK; Moore Z N Engl J Med; 2022 Sep; 387(12):1141-1143. PubMed ID: 36069811 [No Abstract] [Full Text] [Related]
17. Six months of COVID vaccines: what 1.7 billion doses have taught scientists. Ledford H Nature; 2021 Jun; 594(7862):164-167. PubMed ID: 34089016 [No Abstract] [Full Text] [Related]
18. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675 [TBL] [Abstract][Full Text] [Related]
19. First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19. Mazzoni A; Di Lauria N; Maggi L; Salvati L; Vanni A; Capone M; Lamacchia G; Mantengoli E; Spinicci M; Zammarchi L; Kiros ST; Rocca A; Lagi F; Colao MG; Parronchi P; Scaletti C; Turco L; Liotta F; Rossolini GM; Cosmi L; Bartoloni A; Annunziato F; J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33939647 [TBL] [Abstract][Full Text] [Related]
20. Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination. Abbasi J JAMA; 2021 Aug; 326(5):376-377. PubMed ID: 34259836 [No Abstract] [Full Text] [Related] [Next] [New Search]